BioLargo Inc
BioLargo, Inc. invents, develops, and commercializes various platform technologies. The company's technologies solve challenging environmental problems comprising per - and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediati… Read more
BioLargo Inc (BLGO) - Total Assets
Latest total assets as of September 2025: $9.13 Million USD
Based on the latest financial reports, BioLargo Inc (BLGO) holds total assets worth $9.13 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
BioLargo Inc - Total Assets Trend (2000–2024)
This chart illustrates how BioLargo Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
BioLargo Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
BioLargo Inc's total assets of $9.13 Million consist of 67.9% current assets and 32.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 33.8% |
| Accounts Receivable | $3.17 Million | 30.1% |
| Inventory | $330.00K | 3.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $34.00K | 0.3% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2000–2024)
This chart illustrates how BioLargo Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: BioLargo Inc's current assets represent 67.9% of total assets in 2024, an increase from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 33.8% of total assets in 2024, down from 43.2% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2000.
- Asset Diversification: The largest asset category is accounts receivable at 30.1% of total assets.
BioLargo Inc Competitors by Total Assets
Key competitors of BioLargo Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Renxin New Material Co. Ltd. A
SHE:301395
|
China | CN¥1.99 Billion |
|
Engro Corporation Ltd
KAR:ENGRO
|
Pakistan | PKRs765.68 Billion |
|
Fatima Fertilizer Company Ltd
KAR:FATIMA
|
Pakistan | PKRs256.23 Billion |
|
North Huajin Chemical Industries Co Ltd
SHE:000059
|
China | CN¥24.47 Billion |
|
Jiangsu Wujiang China Eastern Silk Market Co Ltd
SHE:000301
|
China | CN¥212.80 Billion |
|
Zangge Holding Co Ltd
SHE:000408
|
China | CN¥16.36 Billion |
|
Sichuan Jinlu Group Co Ltd
SHE:000510
|
China | CN¥2.53 Billion |
|
Jilin Gpro Titanium Industry Co Ltd
SHE:000545
|
China | CN¥2.48 Billion |
BioLargo Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - BioLargo Inc generates 1.69x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - BioLargo Inc is currently not profitable relative to its asset base.
BioLargo Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.67 | 2.31 | 0.42 |
| Quick Ratio | 1.55 | 2.24 | 0.35 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $2.32 Million | $ 4.19 Million | $ -2.04 Million |
BioLargo Inc - Advanced Valuation Insights
This section examines the relationship between BioLargo Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 7.88 |
| Latest Market Cap to Assets Ratio | 4.93 |
| Asset Growth Rate (YoY) | 28.1% |
| Total Assets | $10.51 Million |
| Market Capitalization | $51.87 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values BioLargo Inc's assets at a significant premium ( 4.93x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: BioLargo Inc's assets grew by 28.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for BioLargo Inc (2000–2024)
The table below shows the annual total assets of BioLargo Inc from 2000 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $10.51 Million | +28.13% |
| 2023-12-31 | $8.21 Million | +68.90% |
| 2022-12-31 | $4.86 Million | +60.70% |
| 2021-12-31 | $3.02 Million | -38.83% |
| 2020-12-31 | $4.94 Million | +36.48% |
| 2019-12-31 | $3.62 Million | +13.69% |
| 2018-12-31 | $3.19 Million | +112.98% |
| 2017-12-31 | $1.50 Million | -29.22% |
| 2016-12-31 | $2.11 Million | +10.60% |
| 2015-12-31 | $1.91 Million | +631.92% |
| 2014-12-31 | $261.00K | +56.29% |
| 2013-12-31 | $167.00K | -37.92% |
| 2012-12-31 | $269.00K | +9.35% |
| 2011-12-31 | $246.00K | -46.52% |
| 2010-12-31 | $460.00K | +154.14% |
| 2009-12-31 | $181.00K | -98.19% |
| 2008-12-31 | $10.01 Million | -12.65% |
| 2007-12-31 | $11.46 Million | +4557.72% |
| 2006-12-31 | $246.00K | -13.07% |
| 2005-12-31 | $283.00K | +28200.00% |
| 2003-12-31 | $1.00K | -99.98% |
| 2002-12-31 | $4.37 Million | -4.71% |
| 2001-12-31 | $4.59 Million | -55.21% |
| 2000-12-31 | $10.25 Million | -- |